Core Viewpoint - The company is actively implementing its "Bio+" strategy through the development of a range of bio-fermentation products at its Heilongjiang base, focusing on high-value and technologically advanced offerings [2] Group 1: Company Strategy - The Heilongjiang base is positioned as a center for bio-fermentation products, with a focus on vitamins such as Vitamin C, Coenzyme Q10, Vitamin B5, B12, and amino acids like serine, cysteine, and tryptophan [2] - The company emphasizes a technology-first approach in the development of new products, aiming for a series of high-value, large-scale offerings [2] - There is a strong focus on extending the existing business's industrial chain and creating synergistic effects with current operations [2] Group 2: Research and Development - The company has established a bio-fermentation research institute to foster internal and external collaboration, aiming to stay at the forefront of biotechnology [2] - The goal is to create a comprehensive "Bio+" platform that integrates technology and products deeply [2]

Group 1: Production and Sales - The company has an annual production capacity of 300,000 tons for solid methionine, with a high utilization rate and strong sales performance [2][3] - The liquid methionine project in cooperation with Sinopec, with a capacity of 180,000 tons, has entered the trial production phase and has successfully produced qualified products [3] Group 2: Fragrance and Flavor Products - The fragrance segment includes products such as linalool, citral, and menthol, widely used in personal care, household care, cosmetics, and food [3] - The company is focusing on optimizing product structure and expanding its fragrance product range to enhance core competitiveness [3][4] Group 3: New Materials Sector - The new materials sector is seen as having significant market potential, with a focus on high-performance polymers and key intermediates [3][4] - The Tianjin nylon new materials project is currently in the approval stage, with environmental assessments completed [4] Group 4: Biological Fermentation Products - The Heilongjiang base is focused on biological fermentation products, including Vitamin C and various amino acids, with efforts to improve efficiency and expand the product line [4] - The base aims to develop new products through a technology-first approach, enhancing synergy with existing business segments [4] Group 5: Employee Incentives and Shareholder Returns - The company has completed its employee stock ownership plan and is considering future equity incentive methods to attract talent [4][5] - Since its listing, the company has distributed a total of 15.5 billion yuan in dividends, representing 30%-50% of annual net profits, and is actively repurchasing shares within a range of 300 million to 600 million yuan [5]